Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

  • Harris Technology eyes profitability as refurbished tech sales surge
    Harris Technology eyes profitability as refurbished tech sales surge
    • News

  • QIC Fund Backs Ark Mines with $4.5m to Accelerate Sandy Mitchell Development
    • News

  • Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    • News

  • FBR’s tech could help reduce housing construction-related cost pressures
    FBR’s tech could help reduce housing construction-related cost pressures
    • News

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

ClearVue to commence solar product trials in lucrative China market

  • In News
  • April 23, 2020
  • Alfred Chan
ClearVue to commence solar product trials in lucrative China market

Environmental tech company ClearVue Technologies (ASX: CPV) is poised for a launch into the lucrative Mainland China market having entered an agreement with China Jinmao to trial ClearVue’s solar technology with a view towards exclusive distribution. 

The trial project will be undertaken by China Jinmao’s wholly owned subsidiary Jinmao Green Building which will apply ClearVue’s solar technology into glass and building surfaces, specifically windows, to capture renewable energy. 

“The LOI (Letter of Intent) with Jinmao Green Building Technology Co. Ltd represents fantastic initial first steps towards firming up our market entry strategy for sales in Mainland China,” said ClearView Chairman, Victor Rosenberg. 

“To date our focus in China has been on securing OEM partners for sales outside of Mainland China. Jinmao Green Building is a very well-established brand in the green building space and is supported by its parent, China Jinmao Holdings Group who are leading real estate and hotel developers in the PRC. 

“ClearVue looks forward to completing a successful initial trial building project with Jinmao Green Building in the PRC in this year (subject to the impacts of the COVID-19 virus) with the intent that if successful Jinmao Green Building is subsequently appointed as a distributor for the ClearVue products for sale in Mainland China.”

The trial of ClearVue’s products in China is expected to be completed by the end of September 2020 with ClearVue hopeful of formalising an exclusive distribution contract by the end of the year. 

“We are very much looking forward to working with ClearVue, initially to completing our initial trial and then to exploring how we can introduce the ClearVue product into green building projects in the Mainland China market,” said Dr Chao Zhang, Chief Technology Officer & Dean of Smart Energy Research Institute of Beijing Jinmao Green Building

“We believe that the ClearVue PV product will be a fantastic complement to and a great fit with the range of other green building products and materials we have been introducing into the Mainland Chinese construction industry over the last few years.” 

China Jinmao is listed on the Hong Kong Stock Exchange with a market cap around USD $7.7 billion.

ClearVue shares responded well on news of their Letter of Intent with Jinmao Green Building, opening at $0.12 per share, a rise of 14% on their previous day’s close of $0.105.

Alfred Chan is an Analyst at Emerald Financial, specialising in ASX-listed small cap companies.

 

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  •  
  •  
  •  
  •  
  • asx cpv
  • China
  • China Jinmao
  • ClearVue
  • CPV
  • energy
  • Jinmao Green Building
  • solar
  • Tech
  • Victor Rosenberg
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.